This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Campus
Home
Products

Products

GB only content
admelog logo
Admelog®
Learn morearrow_forward

MAT-XU-2302443 (v3.0) Date of Preparation: October 2023   

Aldurazyme® (laronidase)
Aldurazyme®
Learn morearrow_forward
Prescribing Information GB
Prescribing Information NI

MAT-XU-2200954 (v6.0) Date of Preparation: April 2024  

AVAXIM® (hepatitis A vaccine (inactivated, adsorbed))
Avaxim®
Learn morearrow_forward
Prescribing Information UK

MAT-XU-2301117 (v2.0) Date of preparation: October 2023  

Avaxim® Junior (hepatitis A vaccine (inactivated, adsorbed))
Avaxim® Junior
Learn morearrow_forward
Prescribing Information UK

MAT-XU-2301296 (v3.0) Date of preparation: October 2023  

Cerdelga®▼ (hard capsules eliglustat)
Cerdelga®▼
Learn morearrow_forward
Prescribing Information GB
Prescribing Information IE

MAT-XU-2204064 (v3.0) Date of preparation: October 2023  

Cerezyme® (imiglucerase for injection)
Cerezyme®
Learn morearrow_forward
Prescribing Information GB
Prescribing Information IE

MAT-XU-2204065 (v3.0) Date of preparation: October 2023  

Clexane (enoxaparin)
Clexane®
Learn morearrow_forward
Prescribing Information UK

MAT-XU-2204397 (v4.0) Date of Preparation: October 2023  

Logo dupixent
Dupixent® (dupilumab) Atopic Dermatitis
Learn morearrow_forward
Prescribing Information GB
Prescribing Information NI

MAT-XU-2304409 (v3.0) Date of Preparation May 2024  

Logo dupixent
Dupixent® (dupilumab) Prurigo Nodularis
Learn morearrow_forward
Prescribing Information GB
Prescribing Information NI & RoI

MAT-XU-2400765 (v2.0) Date of Preparation April 2024  

Fabrazyme® (agalsidase beta)
Fabrazyme®
Learn morearrow_forward
Prescribing Information GB
Prescribing Information NI

MAT-GB-2105812 (v6.0) Date of preparation: March 2024  

Lantus® (insulin glargine 100 units/mL)
Lantus®
Learn morearrow_forward
Prescribing Information GB
Prescribing Information NI

MAT-XU-2201444 (v4.0) Date of Preparation: October 2023  

Lemtrada® (alemtuzumab)
Lemtrada®
Learn morearrow_forward
Prescribing Information GB
Prescribing Information NI

MAT-XU-2200680 (v3.0) Date of Preparation: December 2023  

GB only content
MenQuadfiTM▼  (meningococcal (group A,C,W,Y) conjugate vaccine)
MenQuadfiTM▼ 
Learn morearrow_forward
Prescribing Information GB

MAT-XU-2400154 (v2.0) Date of preparation: April 2024  

Myozyme® (alglucosidase alfa)
Myozyme®
Learn morearrow_forward
Prescribing Information GB
Prescribing Information NI

MAT-XU-2302935 (v1.0) Date of preparation: October 2023  

GB only content
Nexviadyme Logo
Nexviadyme®▼
Learn morearrow_forward
Prescribing Information GB

MAT-XU-2203480 (v10.0) Date of preparation: March 2024  

Praluent® (alirocumab)
Praluent®
Learn morearrow_forward
Prescribing Information (GB)
Prescribing Information (NI)

MAT-XU-2204604 (v4.0) Date of Preparation: October 2023  

Quadrivalent Influenza Vaccine (split virion, inactivated)
Quadrivalent Influenza Vaccine
Learn morearrow_forward
Prescribing Information UK

MAT-XU-2301127 (v2.0) Date of preparation: October 2023  

Quadrivalent Influenza Vaccine▼
Learn morearrow_forward
Prescribing Information

MAT-XU-2402066 (v1.0) Date of preparation: June 2024  

Repevax® (diphtheria, tetanus, pertussis and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)
Repevax®
Learn morearrow_forward
Prescribing Information UK

MAT-XU-2301125 (v3.0) Date of preparation: October 2023  

Revaxis® diphtheria, tetanus & poliomyelitis (inactivated) vaccine (absorbed, reduced antigen(s) content)
Revaxis® 
Learn morearrow_forward
Prescribing Information UK

MAT-XU-2301123 (v2.0) Date of preparation: October 2023  

GB only content
rezurock logo
Rezurock®▼
Learn morearrow_forward

MAT-XU-2305107 (v2.0) Date of Preparation: March 2024  

GB only content
Sarclisa Logo
SARCLISA®▼
Learn morearrow_forward
Prescribing Information GB

MAT-XU-2202578 (v3.0) Date of preparation: December 2023  

Stamaril® (yellow fever vaccine (live))
Stamaril®
Learn morearrow_forward
Prescribing Information UK

MAT-XU-2301130 (v2.0) Date of preparation: October 2023  

GB only content
Supemtek▼ (quadrivalent Influenza Vaccine (recombinant, prepared in cell culture))
Supemtek▼
Learn morearrow_forward
Prescribing Information GB

MAT-XU-2301126 (v2.0) Date of preparation: December 2023  

Toujeo® (insulin glargine 300 units/ml)
Toujeo®
Learn morearrow_forward
Prescribing Information GB
Prescribing Information NI

MAT-XU-2302426 (v11.0) Date of Preparation: April 2024  

GB only content
Trurapi logo
Trurapi®▼
Learn morearrow_forward

MAT-XU-2205461 (v9.0)  Date of Preparation: February 2024  

Typhim Vi® (typhoid polysaccharide vaccine)
Typhim Vi®
Learn morearrow_forward
Prescribing Information UK

MAT-XU-2301128 (v2.0) Date of preparation: October 2023  

GB only content
Vaxelis®
Learn morearrow_forward
Prescribing Information GB

MAT-XU-2301124 (v4.0) Date of preparation: April 2024  

Verorab®
Learn morearrow_forward
Prescribing Information (GB)
Prescribing Information (NI)

MAT-XU-2400750 (v2.0) | May 2024  

Viatim®
Learn morearrow_forward
Prescribing Information UK

MAT-XU-2305576(v1.0) Date of preparation: December 2023  

MAT-XU-2305047 (v1.0) - Date of preparation: November 2023